Hello Visitor!
Log In
or
Register
About BIO
BIO International Convention
Blogs
members.bio.org
Media
Contact
About BIO
BIO International Convention
Blogs
members.bio.org
Media
Contact
Home
Advocacy
What is Biotechnology?
Federal Government Relations
About BIO
Board of Directors & Executive Committees
Senior Staff
State Government Relations
International Advocacy
Letters, Testimony & Comments
Alliance Development
Amicus Briefs
Areas of Work
Health Care
Biopharmaceutical Manufacturing and Distribution
Biosimilars
Drug Discovery and Development
Food and Drug Administration Review
Personalized Medicine
Prescription Drug User Fee Act
Reimbursement and Health Policy
Vaccines and Biodefense
Emerging Companies
Capital Formation
Funding
International Market Access
Technology Transfer
Therapeutic Discovery Project Credit
Intellectual Property
Biodiversity and Bioprospecting
Gene Patenting
Patent Law Harmonization
Intellectual Property and Trade
Technology Transfer
Patent Reform
Industrial & Environmental
Advanced Biofuels
Algae
Climate Change
Marine Biotechnology
Renewable Chemicals & Biobased Materials
Renewable Specialty Chemicals
Synthetic Biology
Food & Agriculture
Animal Biotechnology
Plant Biotechnology
Sustainable Agriculture
Public Policy
Regulatory Affairs
State & Local Issues
State Biotech Policy
Stewardship
Bioethics
International Trade
Small Business Early Stage Investment
Conferences & Events
BIO International Convention
Intellectual Property
BIO IP Counsels Committee Conference
Industrial & Environmental
World Congress on Industrial Biotechnology
Pacific Rim Summit on Industrial Biotechnology & Bioenergy
Business Development
BIO Asia International Conference
BIO Convention in China
Food & Agriculture
BIO Livestock Summit
Partnered Events
BioEquity Europe
BIO-Europe
BIO-Europe Spring
Investor Events
BIO CEO & Investor Conference
BIO Investor Forum
Specialized Events
BIO Legislative Day Fly-In
BioSafe Annual General Membership Meeting
Executive Training Programs
Advanced Business Development Course
Business Development Basics
Industry Intelligence & Analysis
Backgrounders
Battelle Report
Agricultural Product Database
BIOtech NOW
Industry Best Practices
Publications
Member Services
Cost Savings / Discounts
Membership/Join BIO
Business Solutions
Membership Dues Schedule
Membership Benefits
Online Membership Application
Suggestion Box
Member Directory
Resources
BIO Grassroots Handbook
Food and Drug Administration
Council of State Bioscience Associations
Government Funding and Grants
IP Counsels Committee
Health Care Reform
Patent and Trademark Office
Securities and Exchange Commission
The Sarbanes-Oxley (SOX) Act
Home
Press Releases
BIO RESPONSE TO ALLEN DRUG PRICING BILL
Apr 4 2001
BIO Opposes Cloning of Humans
Mar 27 2001
BIO Announces First Annual Biotechnology Conference Showcasing Asia and the Pacific Rim
Mar 23 2001
HCFA Nominee, "Knowledgeable Health Care Professional"
Mar 23 2001
STANDARDS FOR PRIVACY OF INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION UNDER THE HEALTH INSURANCE PORTABILITY AND ACCOUNTABILITY ACT
Mar 22 2001
BIO 2001 “Partnering For Life” Preliminary Program Available
Mar 13 2001
BIO REAFFIRMS SUPPORT OF EPA DECISION TO END “SPLIT” BIOTECH CROP APPROVALS
Mar 7 2001
TAX CUTS WOULD BOOST MEDICAL INNOVATIONS
Mar 6 2001
Biotech Ads Seek Ears Of President Bush, D.C. Policymakers
Mar 1 2001
BIO Statement Regarding Nobel Laureates’ Support for Stem Cell Research
Feb 22 2001
Biotech Medicines on the Market Top 110 With Hundreds More in the Pipeline
Feb 16 2001
BIO Welcomes Opening Of New Bipartisan Discussions On Drug Coverage For Medicare Beneficiaries
Feb 15 2001
US Sen. Tim Hutchinson, Newt Gingrich To Participate In BIO’s CEO & Investor Conference
Feb 14 2001
Publication Of Human Genome Sequence Launches New Era In Medicine
Feb 12 2001
BIO Urges Bush To Continue Moratorium On Cloning Human Beings
Feb 1 2001
BIO Letter on Cloning to President Bush
Feb 1 2001
BIO Says Bush Proposal On Medicare Drug Plan Moves Debate In Positive Direction
Jan 30 2001
BIO’s CEO & Investor Conference Features Companies Leading Industry’s Financial Surge On Wall Street
Jan 25 2001
BIO Supportive of FDA Announcement on Biotech Foods
Jan 17 2001
BIO Raises Concerns About FDA’s Proposed Rule On Disclosure Of Gene Therapy Trial Data
Jan 17 2001
BIO names Sharon L. Cohen, senior health policy strategist, as new Vice-President
Jan 9 2001
BIO Issues Statement On PTO’s Final Gene-Based Patent Guidelines
Jan 5 2001
CEO & Investor Conference Expected to Attract 1,500 Biotech Leaders and Investors
Dec 22 2000
BIO names new VP of Government Relations
Dec 18 2000
San Diego To Host BIO 2001 International Convention
Dec 7 2000
« first
‹ previous
…
61
62
63
64
65
66
67
68
69
…
next ›
last »